Prognostic impact of indoleamine 2,3-dioxygenase 1 (IDO1) mRNA expression on circulating tumour cells of patients with head and neck squamous cell carcinomaPanagiota Economopoulou, Amanda Psyrri, Athina Kladi-Skandali et al.|ESMO Open|2020Cited by 30
Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumabPanagiota Economopoulou, Amanda Psyrri, Ioannis G. Panayiotides et al.|Oral Oncology|2020Cited by 17
Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC)Panagiota Economopoulou, Amanda Psyrri, George Koutsodontis et al.|Oral Oncology|2019Cited by 16
Immunotherapy in Nonendemic Nasopharyngeal Carcinoma: Real-World Data from Two Nonendemic RegionsPanagiota Economopoulou, Paolo Bossi, Anastasios Pantazopoulos et al.|Cells|2021Cited by 11
Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).Panagiota Economopoulou, Amanda Psyrri, Nikolaos Spathas et al.|Journal of Clinical Oncology|2019Cited by 4